LONG LASTING PROLIFERATIVE DEFECT IN THE HEMATOPOIETIC STEM-CELL COMPARTMENT FOLLOWING CYTO-TOXIC AGENTS

被引:39
作者
BOTNICK, LE
HANNON, EC
HELLMAN, S
机构
[1] Joint Center for Radiation Therapy, Harvard Medicine School, Boston, MA 02115
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1979年 / 5卷 / 09期
关键词
CFU-C; CFU-S; Cytotoxic; Stem cells;
D O I
10.1016/0360-3016(79)90785-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have reported a significant proliferative defect caused by busulfan and L-phenylalanine mustard (L-PAM) while cyclophosphamide and 5-fluorouracil (5-FU) did not cause such a defect as measured by serial transplantation of bone marrow up to 110 weeks after drug administration. If the proliferative capacity of the initial colony-forming units (CFU-S) as expressed by the ratio (Rs) of the number of CFUs recovered (after 14 days) compared to the number seeding the hind limb prior to transplantation is determined, one finds that the RS correlates with the defect in serial transplantation. Thus, damage to the proliferative capacity of the hematopoietic stem cell caused by chemotherapeutic agents can be expressed in terms of RS, a measure of the self-renewal potential of the stem cell compartment. If RS is assessed after a single drug injection, the pattern of the rise and decline of RS with time following injection offers an efficient method of classifying drug injury to the CFU-S compartment. Busulfan was found to be the most damaging since it killed the most primitive stem cells preferentially. 5-FU was found to be the least damaging to the proliferative capacity of the stem cell compartment while BCNU and cyclophosphamide damaged it in an intermediate way. Therefore, busulfan would be expected to be most damaging to the normal hematopoietic tissue, followed by BCNU, cyclophosphamide and 5-FU in descending order of risk. © 1979.
引用
收藏
页码:1621 / 1625
页数:5
相关论文
共 17 条
[1]  
BONNADONNA G, 1976, NEW ENGL J MED, V294, P405
[2]  
BOTNICK LE, 1978, CANCER RES, V38, P1942
[3]   LIMITED PROLIFERATION OF STEM-CELLS SURVIVING ALKYLATING-AGENTS [J].
BOTNICK, LE ;
HANNON, EC ;
HELLMAN, S .
NATURE, 1976, 262 (5563) :68-70
[4]   LYMPHOCYTE CONTENT + PROLIFERATIVE CAPACITY OF SERIALLY TRANSPLANTED MOUSE BONE MARROW [J].
CUDKOWICZ, G ;
UPTON, AC ;
HUGHES, WL ;
SHEARER, GM .
NATURE, 1964, 201 (491) :165-&
[5]  
DANIEL WD, 1965, P NATL ACAD SCI, V65, P53
[6]   LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS [J].
HAYFLICK, L .
EXPERIMENTAL CELL RESEARCH, 1965, 37 (03) :614-&
[7]   PROLIFERATIVE CAPACITY OF MURINE HEMATOPOIETIC STEM-CELLS [J].
HELLMAN, S ;
BOTNICK, LE ;
HANNON, EC ;
VIGNEULLE, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (01) :490-494
[8]   REVIEW LECTURES ON SENESCENCE .2. HETEROCHRONIC TRANSPLANTATION IN STUDY OF AGEING [J].
KROHN, PL .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1962, 157 (966) :128-+
[9]  
METCALF D, 1971, FRONTIERS BIOLOGY HA, P448
[10]  
MICKLEM HS, 1973, HAEMATOPOIETIC STEM, P285